LRIG1 and neoplasm: Higher expression of LRIG1 was a good prognostic biomarker associated with the prolonged survival outcomes in the ACC, LGG and LUAD cancer patients after adjusting for the abundances of tumor infiltrating immune cells (Figs 4 and S7).